一般的な便中病原体の分子診断検査
Molecular diagnostic testing for common stool pathogens
G. Trafford*, N. Ratnaraja, N. Wickramasinghe
*Heart of England Foundation Trust, UK
Journal of Hospital Infection (2015) 90, 196-198
No abstract.
サマリー原文(英語)はこちら
監訳者コメント:
便中の腸管病原体の検出に、日常的な検査として遺伝子検査が用いられるケースはこれまで少なかった。しかしながら、従来法は感度や手間、費用などの点で制約が大きかったのも事実である。本稿は、PCR 法を用いる長所、ピットフォール、結果の解釈、コスト比較など、実用化と感染対策への応用に向けた課題について述べている。
同カテゴリの記事
Successful control of an outbreak of GES-5 extended-spectrum β-lactamase-producing Pseudomonas aeruginosa in a long-term care facility in Japan
Application of the appropriate molecular biology-based method significantly increases the sensitivity of group B streptococcus detection results
T. Bogiel*, D. Depka, P. Zalas-Więcek, M. Rzepka, E. Kruszyńska, E. Gospodarek-Komkowska
*Nicolaus Copernicus University in Toruń, Poland
Journal of Hospital Infection (2021) 112, 21-26
Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality X.H.S. Chan*, C.J. O’Connor, E. Martyn, A.J. Clegg, B.J.K. Choy, A.L. Soares, R. Shulman, N.R.H. Stone, S. De, J. Bitmead, L. Hail, D. Brealey, N. Arulkumaran, M. Singer, A.P.R. Wilson *University College London NHS Foundation Trust, UK Journal of Hospital Infection (2022) 124, 37-46
Effectiveness of the CareCentre® at improving contact precautions: randomized simulation and clinical evaluations
Indwelling urethral versus suprapubic catheters in nursing home residents: determining the safest option for long-term use
